131 related articles for article (PubMed ID: 35228032)
1. LXA4 enhances prostate cancer progression by facilitating M2 macrophage polarization via inhibition of METTL3.
Jia G; Wang X; Wu W; Zhang Y; Chen S; Zhao J; Zhao W; Li W; Sun X; Han B
Int Immunopharmacol; 2022 Jun; 107():108586. PubMed ID: 35228032
[TBL] [Abstract][Full Text] [Related]
2. Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2-IRF pathway.
Yuan J; Lin F; Chen L; Chen W; Pan X; Bai Y; Cai Y; Lu H
Inflammopharmacology; 2022 Apr; 30(2):487-498. PubMed ID: 35235107
[TBL] [Abstract][Full Text] [Related]
3. Mechanical stress protects against chondrocyte pyroptosis through lipoxin A
Shen P; Jia S; Wang Y; Zhou X; Zhang D; Jin Z; Wang Z; Liu D; Bai L; Yang Y
Biomed Pharmacother; 2022 Sep; 153():113361. PubMed ID: 35797941
[TBL] [Abstract][Full Text] [Related]
4. In vitro phenotypic effects of Lipoxin A4 on M1 and M2 polarized macrophages derived from THP-1.
Aubeux D; Tessier S; Pérez F; Geoffroy V; Gaudin A
Mol Biol Rep; 2023 Jan; 50(1):339-348. PubMed ID: 36331745
[TBL] [Abstract][Full Text] [Related]
5. Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.
Moreno C; Prieto P; Macías Á; Pimentel-Santillana M; de la Cruz A; Través PG; Boscá L; Valenzuela C
J Immunol; 2013 Dec; 191(12):6136-46. PubMed ID: 24249731
[TBL] [Abstract][Full Text] [Related]
6. The
Liu Y; Liu Z; Tang H; Shen Y; Gong Z; Xie N; Zhang X; Wang W; Kong W; Zhou Y; Fu Y
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C762-C775. PubMed ID: 31365297
[TBL] [Abstract][Full Text] [Related]
7. Lipoxin A4 redistributes myosin IIA and Cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytes.
Reville K; Crean JK; Vivers S; Dransfield I; Godson C
J Immunol; 2006 Feb; 176(3):1878-88. PubMed ID: 16424219
[TBL] [Abstract][Full Text] [Related]
8. Lipoxin A
Simões RL; De-Brito NM; Cunha-Costa H; Morandi V; Fierro IM; Roitt IM; Barja-Fidalgo C
Int J Cancer; 2017 Jan; 140(2):346-357. PubMed ID: 27615282
[TBL] [Abstract][Full Text] [Related]
9. The atheroprotective role of lipoxin A
Mai J; Liu W; Fang Y; Zhang S; Qiu Q; Yang Y; Wang X; Huang T; Zhang H; Xie Y; Lin M; Chen Y; Wang J
Atherosclerosis; 2018 Nov; 278():259-268. PubMed ID: 30340110
[TBL] [Abstract][Full Text] [Related]
10. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
Romano M; Maddox JF; Serhan CN
J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
[TBL] [Abstract][Full Text] [Related]
11. CTHRC1 in Ovarian Cancer Promotes M2-Like Polarization of Tumor-Associated Macrophages via Regulation of the STAT6 Signaling Pathway.
Bai Y; Yin K; Su T; Ji F; Zhang S
Onco Targets Ther; 2020; 13():5743-5753. PubMed ID: 32606786
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer.
Schnittert J; Heinrich MA; Kuninty PR; Storm G; Prakash J
Cancer Lett; 2018 Apr; 420():247-258. PubMed ID: 29408203
[TBL] [Abstract][Full Text] [Related]
13. Amnion Epithelial Cells Promote Lung Repair via Lipoxin A
Tan JL; Tan YZ; Muljadi R; Chan ST; Lau SN; Mockler JC; Wallace EM; Lim R
Stem Cells Transl Med; 2017 Apr; 6(4):1085-1095. PubMed ID: 28371562
[TBL] [Abstract][Full Text] [Related]
14. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
15. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer.
Zong L; Chen K; Jiang Z; Chen X; Sun L; Ma J; Zhou C; Xu Q; Duan W; Han L; Lei J; Li X; Ma Q; Wang Z
J Exp Clin Cancer Res; 2017 Dec; 36(1):181. PubMed ID: 29228980
[TBL] [Abstract][Full Text] [Related]
16. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
Parkinson JF
Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Associated Macrophages Promote Oxaliplatin Resistance
Lan H; Liu Y; Liu J; Wang X; Guan Z; Du J; Jin K
Mol Pharm; 2021 Mar; 18(3):1026-1037. PubMed ID: 33555197
[TBL] [Abstract][Full Text] [Related]
18. Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis.
Walker J; Dichter E; Lacorte G; Kerner D; Spur B; Rodriguez A; Yin K
Shock; 2011 Oct; 36(4):410-6. PubMed ID: 21701419
[TBL] [Abstract][Full Text] [Related]
19. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction.
Fiore S; Serhan CN
Biochemistry; 1995 Dec; 34(51):16678-86. PubMed ID: 8527441
[TBL] [Abstract][Full Text] [Related]
20. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation.
Kure I; Nishiumi S; Nishitani Y; Tanoue T; Ishida T; Mizuno M; Fujita T; Kutsumi H; Arita M; Azuma T; Yoshida M
J Pharmacol Exp Ther; 2010 Feb; 332(2):541-8. PubMed ID: 19846590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
